Atlas Trials

WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma

Clinical trial NCT05925764 · RECRUITING

Trial details

NCT number
NCT05925764
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
RECRUITING
Study type
OBSERVATIONAL
Lung AdenocarcinomaWhole Slide ImageIASLC Grading SystemArtificial Intelligence
Start date
2024-10-15
Primary completion
2024-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.